Marvin Rotman

Active 1980–2018

58
Papers
26,842
Citations
58
h-index
58
i10-index

Citations

Citations per year for Marvin Rotman1959: 1 citations1980: 2 citations1981: 2 citations1982: 4 citations1983: 3 citations1984: 2 citations1985: 7 citations1986: 4 citations1987: 6 citations1988: 9 citations1989: 7 citations1990: 9 citations1991: 16 citations1992: 16 citations1993: 19 citations1994: 16 citations1995: 28 citations1996: 31 citations1997: 57 citations1998: 49 citations1999: 58 citations2000: 93 citations2001: 107 citations2002: 120 citations2003: 129 citations2004: 132 citations2005: 171 citations2006: 165 citations2007: 190 citations2008: 163 citations2009: 166 citations2010: 191 citations2011: 168 citations2012: 151 citations2013: 168 citations2014: 152 citations2015: 144 citations2016: 120 citations2017: 125 citations2018: 100 citations2019: 507 citations2020: 484 citations2021: 343 citations2022: 248 citations2023: 150 citations2024: 279 citations2025: 110 citations1960–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,292 citing papers, 34.2% of this breakdownCanada: 414 citing papers, 6.2% of this breakdownUnited Kingdom: 358 citing papers, 5.3% of this breakdownGermany: 349 citing papers, 5.2% of this breakdownChina: 310 citing papers, 4.6% of this breakdownItaly: 297 citing papers, 4.4% of this breakdownFrance: 281 citing papers, 4.2% of this breakdownNetherlands: 258 citing papers, 3.8% of this breakdownJapan: 235 citing papers, 3.5% of this breakdownSwitzerland: 150 citing papers, 2.2% of this breakdownAustralia: 148 citing papers, 2.2% of this breakdownIndia: 131 citing papers, 2% of this breakdown
0%34.2%Other 22.2%

Fields

  • Medicine90.2%
  • Biochemistry, Genetics and Molecular Biology4.4%
  • Physics and Astronomy2.1%
  • Engineering0.7%
  • Immunology and Microbiology0.7%
  • Neuroscience0.5%
  • Other1.4%

Topics

  • Brain Metastases and Treatment7.7%
  • Glioma Diagnosis and Treatment6.5%
  • Head and Neck Cancer Studies6.3%
  • Endometrial and Cervical Cancer Treatments5.3%
  • Advanced Radiotherapy Techniques4.3%
  • Lung Cancer Research Studies4%
  • Other65.9%

Coauthors

All papers

Open in search
  1. Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 3,256

  2. A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study

    Authors: , , , , , - Gynecologic Oncology 1999 cited by 1,341

  3. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

    Authors: , , , , , , , , , , , , , - The Lancet 2004 cited by 2,426

  4. Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer

    Authors: , , , , , , , , - New England Journal of Medicine 1999 cited by 2,331

  5. Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

    Authors: , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2012 cited by 605

  6. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

    Authors: , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1997 cited by 2,556

  7. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study

    Authors: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2006 cited by 608

  8. Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 701

  9. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2018 cited by 231

  10. Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01

    Authors: , , , , , , , , - Journal of Clinical Oncology 2004 cited by 1,019

  11. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 1996 cited by 1,089

  12. Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

    Authors: , , , , , , , , , , - JNCI Journal of the National Cancer Institute 1993 cited by 1,312

  13. RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal

    Authors: , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2012 cited by 624

  14. Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 139

  15. Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

    Authors: , , , , , , , , - Head & Neck 2007 cited by 361

  16. Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 218

  17. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials

    Authors: , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1993 cited by 535

  18. Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2003 cited by 639

  19. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group

    Authors: , , , , , , , , , - Cancer 1980 cited by 460

  20. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

    Authors: , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2001 cited by 175

  21. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902

    Authors: , , , , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2015 cited by 78

  22. Prophylactic Extended-Field Irradiation of Para-aortic Lymph Nodes in Stages IIB and Bulky IB and IIA Cervical Carcinomas

    Authors: - JAMA 1995 cited by 362

  23. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group☆

    Authors: , , , , , , , - Gynecologic Oncology 2003 cited by 269

  24. Survival outcomes with the use of surgery in limited‐stage small cell lung cancer

    Authors: , , , , , , , , - Cancer 2010 cited by 219